Please assess the completion status of the following clinical trial:

Trial Title: Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients experiencing their first psychotic episode~* Male or Female~* Aged 15-25~Exclusion Criteria:~* Previous treatment with antipsychotic medication (longer than 1 week)~* History of a clinically significant physical illness~* Organic disorder presenting with psychotic symptoms

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).